Typcal is a startup. Brouky records 1 investor associated with the company.
Typcal develops proprietary fungal strains to produce mycelium-based protein and fibre via biomass fermentation. Their strains are claimed to grow faster and on a wider range of feedstocks than competing technologies, aiming for scalable sustainable protein and fibre production.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.